GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (OCSE:GUBRA) » Definitions » Total Long-Term Assets

Gubra AS (OCSE:GUBRA) Total Long-Term Assets : kr83.2 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Gubra AS's Total Long-Term Assets for the quarter that ended in Dec. 2023 was kr83.2 Mil.


Gubra AS Total Long-Term Assets Historical Data

The historical data trend for Gubra AS's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Total Long-Term Assets Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Long-Term Assets
80.39 78.20 95.26 70.89 83.25

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Total Long-Term Assets Get a 7-Day Free Trial 95.26 - 70.89 83.75 83.25

Gubra AS Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.


Gubra AS Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Gubra AS's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS (OCSE:GUBRA) Business Description

Traded in Other Exchanges
Address
Hørsholm Kongevej 11B, Hørsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases.

Gubra AS (OCSE:GUBRA) Headlines

No Headlines